[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU2016112886A - Оральная противопаразитарная композиция - Google Patents

Оральная противопаразитарная композиция Download PDF

Info

Publication number
RU2016112886A
RU2016112886A RU2016112886A RU2016112886A RU2016112886A RU 2016112886 A RU2016112886 A RU 2016112886A RU 2016112886 A RU2016112886 A RU 2016112886A RU 2016112886 A RU2016112886 A RU 2016112886A RU 2016112886 A RU2016112886 A RU 2016112886A
Authority
RU
Russia
Prior art keywords
composition
use according
eugenia
eucalyptus
essential oil
Prior art date
Application number
RU2016112886A
Other languages
English (en)
Other versions
RU2712765C2 (ru
RU2016112886A3 (ru
Inventor
Александр ФЕЖЬЕ
Николя ЛЕРУКСЕЛЬ
Original Assignee
Марс, Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Марс, Инкорпорейтед filed Critical Марс, Инкорпорейтед
Publication of RU2016112886A publication Critical patent/RU2016112886A/ru
Publication of RU2016112886A3 publication Critical patent/RU2016112886A3/ru
Application granted granted Critical
Publication of RU2712765C2 publication Critical patent/RU2712765C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/02Ammonia; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (24)

1. Композиция для применения в качестве перорального противопаразитарного средства, где композиция содержит одно или более из:
i) эфирного масла, которое содержит гамма-терпинен, и/или корвакрол, и/или тимол, и/или терпиненол, и/или эвкалиптол, и/или эвгенол,
ii) эфирного масла из рода Cinnamomum, Eugenia, Eucalyptus,
iii) источника сапонина.
2. Композиция для применения по п.1, которая содержит эфирное масло, содержащее гамма-терпинен, и/или корвакрол, и/или тимол, и/или терпиненол, и/или эвкалиптол и/или эвгенол, и эфирное масло из рода Cinnamomum, Eugenia, Eucalyptus.
3. Композиция для применения по п.1 или 2, где эфирное масло, которое содержит гамма-терпинен, и/или корвакрол, и/или тимол, и/или терпиненол, и/или эвкалиптол, и/или эвгенол, включает род Satureja, Thymus, Trachyspermum, Origanum или Melaleuca.
4. Композиция для применения по любому из пп.1-3, где композиция содержит одно или несколько эфирных масел из рода Cinnamomum, Eugenia, Eucalyptus.
5. Композиция для применения по любому из пп.1-4, где источник сапонина содержит смесь стероидного сапонигенина.
6. Композиция для применения по любому из пп.1-5, для применения к кошке или собаке.
7. Композиция для применения по любому из пп.1-6, где композиция представляет собой жидкость, таблетку или кормовой продукт.
8. Композиция для применения по любому из пп.1-7, где композиция введена в желатинированную крахмальную матрицу или влажный продукт.
9. Композиция для применения по любому из пп.1-8, где паразит относится к виду Apicomplexa, необязательно паразит относится к классу Сonoidasida.
10. Композиция для применения по п.9, где паразит представляет собой Neospora canicum или Toxoplasma gondii.
11. Способ профилактики или лечения паразитарной инфекции у животного, где способ включает введение пероральным путем указанному животному композиции, содержащей одно или более из
iv) эфирного масла, которое содержит гамма-терпинен, и/или корвакрол, и/или тимол, и/или терпиненол, и/или эвкалиптол,
v) эфирного масла рода Cinnamomum, Eugenia, Eucalyptus,
vi) источника сапонина.
12. Композиция, содержащая два или более из следующих эфирных масел рода Cinnamomum, Eugenia, Satureja, Thymus, Trachyspermum, Origanum, Eucalyptus, или Melaleuca.
13. Композиция, содержащая источник сапонина и одно или более из
i) эфирного масла, которое содержит гамма-терпинен, и/или корвакрол, и/или тимол, и/или терпиненол, и/или эвкалиптол, и/или эвгенол, или
ii) эфирного масло из рода Cinnamomum, Eugenia, Eucalyptus.
14. Способ получения композиции по п.12 или 13, включающий смешивание вместе ингредиентов и необязательно приведение смеси в форму, подходящую для композиции и введения.
15. Способ по п.14, в котором композиция добавлена к смеси в форме спрея, покрытия или заключена в желатинированной крахмальной матрице.
16. Композиция по п.12 или 13 для применения в качестве противопаразитарного средства.
RU2016112886A 2013-09-06 2014-09-05 Оральная противопаразитарная композиция RU2712765C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13306227.3 2013-09-06
EP13306227 2013-09-06
PCT/EP2014/068992 WO2015032922A1 (en) 2013-09-06 2014-09-05 Oral anti-parasitic composition

Publications (3)

Publication Number Publication Date
RU2016112886A true RU2016112886A (ru) 2017-10-11
RU2016112886A3 RU2016112886A3 (ru) 2018-05-30
RU2712765C2 RU2712765C2 (ru) 2020-01-31

Family

ID=49223705

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016112886A RU2712765C2 (ru) 2013-09-06 2014-09-05 Оральная противопаразитарная композиция

Country Status (13)

Country Link
US (1) US11497785B2 (ru)
EP (1) EP3041579B1 (ru)
JP (2) JP6310084B2 (ru)
CN (1) CN105682669B (ru)
AU (2) AU2014317025B2 (ru)
CA (1) CA2920723A1 (ru)
DK (1) DK3041579T3 (ru)
ES (1) ES2947500T3 (ru)
FI (1) FI3041579T3 (ru)
FR (1) FR3010315A1 (ru)
GB (1) GB201404505D0 (ru)
RU (1) RU2712765C2 (ru)
WO (1) WO2015032922A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201404505D0 (en) 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
WO2016187422A1 (en) * 2015-05-19 2016-11-24 Ralco Nutrition, Inc. Essential oil compositions and applications utilizing essential oils
CN107439819A (zh) * 2017-09-15 2017-12-08 邹百川 一种驱蚊仔猪饲料
CN111675746A (zh) * 2020-05-29 2020-09-18 广东省农业科学院动物卫生研究所 科罗索酸及其衍生物在制备抗柔嫩艾美耳球虫的药物中的应用
CN111513211A (zh) * 2020-06-01 2020-08-11 广州市天朝生物科技有限公司 一种用于畜禽与水产养殖的水溶性营养精油及其制备方法和应用
CN114848717B (zh) * 2022-04-07 2023-09-26 广东药科大学 一种芳香南药复方精油及其制备方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197319A (en) * 1977-11-10 1980-04-08 Ralston Purina Company Feed intake limiting composition for ruminants
FR2460136B1 (fr) * 1979-07-05 1986-01-10 Synthelabo Compositions pharmaceutiques contenant des extraits de lierre grimpant
GB2114439A (en) * 1982-02-11 1983-08-24 Edwards Paolina Artine A medecine
AU2314184A (en) 1983-01-10 1984-07-12 Robert Young & Company Limited Endoparasiticidal composition containing levamisole
JPH0746963A (ja) 1993-08-06 1995-02-21 Nippon Terupen Kagaku Kk 家畜用飼料
TR199701441T1 (xx) * 1995-05-26 1998-02-21 Ropapharm B.V. �nsan ve hayvanlarla ilgili t�p alan�nda kullan�lmak �zere bitkilerden elde edilen eterli ya�lar baz�ndaki farmas�tik terkipler.
US5639794A (en) * 1995-06-07 1997-06-17 Proguard, Inc. Use of saponin in methods and compositions for pathogen control
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
FR2773711B1 (fr) * 1998-01-16 2001-05-04 Andre Pierre Morice Composition comprenant du miel, au moins une huile essentielle et/ou au moins un derive d'une huile essentielle
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray
US5955086A (en) * 1998-06-18 1999-09-21 Biotics Research Corporation Oregano for the treatment of internal parasites and protozoa
JP2003521463A (ja) 1998-12-22 2003-07-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗原虫性サポニン
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
GB9912443D0 (en) 1999-05-27 1999-07-28 Barrier Biotech Limited Antiparasitic formulation
TWI223595B (en) * 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
JP2001247424A (ja) * 2000-03-06 2001-09-11 Sumika Life Tech Co Ltd 動物の外部寄生虫防除剤
EP1178104A1 (en) * 2000-08-03 2002-02-06 Société des Produits Nestlé S.A. Use of essential oils for combatting GI tract infection by helicobacter-like organisms
GB0022337D0 (en) * 2000-09-12 2000-10-25 Barrier Biotech Ltd An antimicrobial composition
NZ530808A (en) 2001-07-27 2006-09-29 Alltech Inc Preventing or reducing coccidial infection in a non-human animal comprising administering a composition comprising yeast cell walls
CN1521182A (zh) * 2003-01-28 2004-08-18 中国人民解放军第二军医大学 一种桉属植物提取物及其用途
DE10306987A1 (de) * 2003-02-19 2004-09-02 Bonapharm Gmbh Zubereitung auf Basis von Teebaumöl sowie Verfahren zu ihrer Herstellung und ihre Verwendung
CN1331601C (zh) 2003-05-16 2007-08-15 中国科学院上海有机化学研究所 手性氨基醇配体应用于端炔对含氟烷基芳基酮的不对称加成的方法
DK1694136T3 (da) * 2003-11-26 2012-04-10 Hills Pet Nutrition Inc Fremgangsmåde til at mindske lugt af ekskrementer fra selskabsdyr
US7687077B2 (en) * 2003-11-26 2010-03-30 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
RS51374B (sr) * 2004-02-06 2011-02-28 Vojin Gligovic Primena prirodnog i sintetičkog eugenola kao dodatak stočnoj hrani
JP5010809B2 (ja) 2005-04-28 2012-08-29 日清丸紅飼料株式会社 養殖魚の寄生虫寄生軽減剤、養殖魚の寄生虫寄生軽減用飼料及び養殖魚の飼育方法
WO2006120495A1 (fr) 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
US8753676B2 (en) 2006-02-15 2014-06-17 Botanocap Ltd. Applications of microencapsulated essential oils
US8293286B2 (en) 2006-10-16 2012-10-23 Sergeant's Pet Care Products, Inc. Natural compositions for killing parasites on a companion animal
JP5101081B2 (ja) 2006-10-31 2012-12-19 日清丸紅飼料株式会社 コクシジウム症・クロストリジウム症の予防及び/又は治療用飼料
US20080193387A1 (en) * 2007-02-14 2008-08-14 Ricki De Wolff Essential oil compositions for killing or repelling ectoparasites and pests and methods for use thereof
AU2008275599B2 (en) * 2007-07-11 2014-03-06 Healthymouth, Llc. Composition and packaging method for animal dental care
CN101827588B (zh) * 2007-10-18 2012-11-28 帝斯曼知识产权资产管理有限公司 用于认知功能的含有百里香酚和/或对-伞花烃的新颖的药物组合物或植物提取物
US20110008471A1 (en) 2007-12-27 2011-01-13 Tyratech, Inc. Synergistic antiparasitic compositions and screening methods
US20090285886A1 (en) 2008-05-14 2009-11-19 Van Beek Ronald R Enhanced antimicrobial activity of plant essential oils
EP2451468B1 (en) 2009-07-08 2017-01-11 Onikolabs LLC Topical antifungal composition
EP2301368A1 (en) * 2009-09-08 2011-03-30 Mars, Incorporated Composition for prevention against spoilage by microorganisms and uses and products related thereto
PL2480090T3 (pl) 2009-09-24 2014-04-30 Unilever Nv Środek dezynfekujący zawierający eugenol, terpineol oraz tymol
CN101919852B (zh) * 2010-02-08 2013-06-19 华南农业大学 一种宠物体外抗虫喷剂及其制备和使用方法
FR2958851B1 (fr) 2010-04-16 2012-06-29 Xeda International Nouvelles formulations d'ingredient(s) actif(s) d'origine vegetale ou leurs analogues synthetiques ou d'extrait(s) d'origine vegetale les contenant, et de lecithine
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
US9492398B2 (en) 2011-02-25 2016-11-15 Eydo Pharma Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
WO2012176131A1 (en) * 2011-06-21 2012-12-27 Pharmayeda Ltd. Compositions and methods useful for treating pediculosis
US20140106012A1 (en) 2011-06-21 2014-04-17 Pharmayeda Ltd. Compositions and methods useful for treating pediculosis
CN102274177A (zh) * 2011-08-24 2011-12-14 西北农林科技大学 一种复方百里香酚纳米药物及其制备方法
US9999218B2 (en) 2011-10-04 2018-06-19 0903608 B.C. Ltd. Pest control formulations and methods of making and using same
EP2763541B1 (en) * 2011-10-04 2023-06-07 0903608 B.C. Ltd. Pest control formulations and methods of making and using same
WO2013070441A1 (en) * 2011-11-10 2013-05-16 Messina James J Combination animal repellents
US9271486B2 (en) 2011-11-10 2016-03-01 James J. Messina Combination animal repellents
CN102397379B (zh) * 2011-11-19 2014-07-09 西北农林科技大学 一种复方水包油型黄柏油纳米乳组合物
GB201404505D0 (en) 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition

Also Published As

Publication number Publication date
JP2016536331A (ja) 2016-11-24
JP6666941B2 (ja) 2020-03-18
AU2020201643B2 (en) 2022-03-17
US11497785B2 (en) 2022-11-15
CN105682669B (zh) 2020-08-18
RU2712765C2 (ru) 2020-01-31
FR3010315A1 (fr) 2015-03-13
EP3041579A1 (en) 2016-07-13
GB201404505D0 (en) 2014-04-30
AU2014317025B2 (en) 2019-12-05
JP6310084B2 (ja) 2018-04-11
WO2015032922A1 (en) 2015-03-12
JP2018138547A (ja) 2018-09-06
CA2920723A1 (en) 2015-03-12
RU2016112886A3 (ru) 2018-05-30
ES2947500T3 (es) 2023-08-10
FI3041579T3 (fi) 2023-06-13
CN105682669A (zh) 2016-06-15
AU2020201643A1 (en) 2020-03-19
DK3041579T3 (da) 2023-06-19
EP3041579B1 (en) 2023-03-22
US20160206676A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
RU2016112886A (ru) Оральная противопаразитарная композиция
MX2022008663A (es) Composiciones alergenicas mixtas y metodos de uso de las mismas.
BR112014028232A2 (pt) formulações para atração de inseto e controle de inseto
UA101903C2 (ru) Лекарственное средство на основе дииндолилметана для лечения гиперпластических и воспалительных заболеваний
MX354942B (es) Composiciones para la administración oral a animales, procedimientos de obtención de las mismas y sus usos.
AR092566A1 (es) Composiciones grasas para mantener una palatabilidad de alimentos para animales domesticos en el tiempo
EA201500873A1 (ru) Антимикробные композиции и способы их применения
BR112014018096A2 (pt) péletes compreendendo amido e proteína, processo para obtenção destes e uso dos mesmos
AR108769A1 (es) Procedimiento de preparación de un alimento con polvo dispersable en agua que contiene un componente de semilla de legumbre descascarada
CL2015002832A1 (es) Formulación farmaceutica que comprende fosfatidilcolina para el tratamiento de colitus ulcerosa.
ECSP19044591A (es) Amidas aromáticas de ácido carboxílico como antagonistas del receptor b1 de la bradiquinina
MX367524B (es) Composición rodenticida de cebo blando.
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
MX2016003619A (es) Composicion de grasa comestible.
WO2016036324A3 (en) Novel plant functional activated nano vacc-fertiliceutical, and methods of preparation, formulation, dilution, and use thereof
RU2012110048A (ru) Пищевой продукт, обладающий лечебно-профилактическими свойствами
PH12019500024A1 (en) Pharmaceutical compositions
MD20140110A2 (ru) Лекарственное средство для лечения мастита у крупного рогатого скота и способ его получения
CL2016003044A1 (es) Composiciones estructuradas de grasa vegetal, proceso para obtener dicha composición estructurada de grasas, uso de la composición estructurada de grasas en la preparación de una composición cosmética, composición cosmética y producto que comprende dicha composición estructurada de grasas
CN105616242A (zh) 一种花露水
MX2022013576A (es) Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.
CL2012002768A1 (es) Solucion antiseptica para prevencion de mastitis subclinica en vacas lecheras que comprende una mezcla de propoleo y solucion de miel de abejas en proporciones desde 1:5 a 5:1, uso de la solucion antiseptica porque sirve para la profilaxis, prevencion y control de mastitis subclinica de vacas lecheras.
GB2536072A8 (en) Method for determination of the choice of the active ingredients of biological and chemical composition against infectious, oncology, skin diseases, which are
TR201910310T4 (tr) Arı ürünlerini içeren bileşim.
Ribeiro-Santosa et al. Physical and optical properties of whey protein films incorporating essential oils